May 8 - UnitedHealth (NYSE:UNH) is staring down a proposed class-action lawsuit, with investors claiming the healthcare giant misled them about key financial risks. The lawsuit names CEO Andrew Witty and CFO John Rex as co-defendants, alleging they failed to come clean about the fallout from the sudden death of former top executive Brian Thompson on Dec. 4, 2024. Investors argue the company downplayed the impact of strategic changes and a critical U.S. Senate report from Oct. 17, 2024, that highlighted high claim denial rates. Warning! GuruFocus has detected 4 Warning Sign with UNH. Shares of UNH remains down 23% YTD.UnitedHealth Slammed with Lawsuit Over 'Wrongful Acts' The suit seeks unspecified damages for those who held shares between Dec. 3, 2024, and April 16, 2025. Is UHN Stock a Buy Now ?UnitedHealth Slammed with Lawsuit Over 'Wrongful Acts' Based on the one year price targets offered by 25 analysts, the average target price for UnitedHealth Group Inc is $549.91 with a high estimate of $677.00 and a low estimate of $490.00. The average target implies a upside of +40.62% from the current price of $391.06. Based on GuruFocus estimates, the estimated GF Value for UnitedHealth Group Inc in one year is $707.40, suggesting a upside of +80.89% from the current price of $391.06. This article first appeared on GuruFocus. View Comments
UnitedHealth Slammed with Lawsuit Over 'Wrongful Acts'
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...